Contemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIV
- 27 Downloads
Purpose of Review
Metabolic comorbidities including diabetes, obesity, dyslipidemia, and hypertension, all of which are traditional cardiovascular disease risk factors that are highly prevalent in people with HIV (PWH). Bone disease including osteopenia, osteoporosis, and fragility fractures is also prevalent in PWH. These comorbidities may be prevented and treated in part with lifestyle modification, including changes to dietary and physical habits. The purpose of this review is to highlight recent literature that characterizes current lifestyle habits in PWH as well as the effectiveness of lifestyle strategies to improve metabolic comorbidities prevalent in PWH.
Recent studies have expanded our knowledge regarding the current lifestyle habits of PWH as well as the potential for lifestyle modification to prevent or improve comorbidities prevalent in PWH. Clinical trials focusing on lifestyle modification have shown some benefit of such interventions on traditional risk factors for comorbidities; however, significant heterogeneity exists between studies and results are not consistent.
Further clinical trials are needed including developing lifestyle strategies that are feasible, effective, and sustainable to prevent and decrease prevalence of comorbidities in this population.
KeywordsHIV Lifestyle modification Diet Physical activity Metabolic comorbidities Bone disease
Compliance with Ethical Standards
Conflict of Interest
Ms. Fitch reports personal fees from Gilead Sciences, Inc., from Merck, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
- 7.Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;4:1–9.Google Scholar
- 14.Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol. 2019;7(6):452–61.PubMedCrossRefPubMedCentralGoogle Scholar
- 17.Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013.Google Scholar
- 18.National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Washington: National Osteoporosis Foundation; 2014.Google Scholar
- 19.Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5):651–81.PubMedCrossRefPubMedCentralGoogle Scholar
- 20.Schwingshackl L, Bogensberger B, Hoffmann G. Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: an updated systematic review and meta-analysis of cohort studies. J Acad Nutr Diet. 2018;118(1):74–100 e11.PubMedCrossRefPubMedCentralGoogle Scholar
- 30.Marzel A, Kouyos RD, Reinschmidt S, Balzer K, Garon F, Spitaleri M, et al. Dietary patterns and physical activity correlate with total cholesterol independently of lipid-lowering drugs and antiretroviral therapy in aging people living with human immunodeficiency virus. Open Forum Infect Dis. 2018;5(4):ofy067.PubMedPubMedCentralCrossRefGoogle Scholar
- 36.Global recommendations on physical activity for health. In: Organization WH, editor. Switzerland 2010.Google Scholar
- 48.Ladapo JA, Richards AK, DeWitt CM, Harawa NT, Shoptaw S, Cunningham WE, et al. Disparities in the quality of cardiovascular care between HIV-infected versus HIV-uninfected adults in the United States: a cross-sectional study. J Am Heart Assoc. 2017;6(11):e007107.PubMedPubMedCentralCrossRefGoogle Scholar
- 52.Zanetti HR, da Cruz LG, Lourenco CL, Ribeiro GC, de Ferreira Jesus Leite MA, Neves FF, et al. Nonlinear resistance training enhances the lipid profile and reduces inflammation marker in people living with HIV: a randomized clinical trial. J Phys Act Health. 2016;13(7):765–70.PubMedCrossRefPubMedCentralGoogle Scholar
- 56.Ezema CI, Onwunali AA, Lamina S, Ezugwu UA, Amaeze AA, Nwankwo MJ. Effect of aerobic exercise training on cardiovascular parameters and CD4 cell count of people living with human immunodeficiency virus/acquired immune deficiency syndrome: a randomized controlled trial. Niger J Clin Pract. 2014;17(5):543–8.PubMedCrossRefPubMedCentralGoogle Scholar
- 57.Balducci S, Zanuso S, Cardelli P, Salvi L, Bazuro A, Pugliese L, et al. Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian diabetes and exercise study (IDES). PLoS One. 2012;7(11):e49297.PubMedPubMedCentralCrossRefGoogle Scholar
- 59.Stradling C, Thomas GN, Hemming K, Taheri S, Taylor S, Ross J, et al. The Mediterranean portfolio diet in HIV dyslipidaemia: a randomized controlled trial. Seattle: Conference on Retroviruses and Opportunistic Infections; 2018.Google Scholar
- 61.Duncan AD, Peters BS, Rivas C, Goff LM Reducing risk of type 2 diabetes in HIV: a mixed-methods investigation of the STOP-diabetes diet and physical activity intervention. Diabetic Med. 2019Google Scholar
- 63.Wing RR, Becofsky K, Wing EJ, McCaffery J, Boudreau M, Evans EW, et al. Behavioral and cardiovascular effects of a behavioral weight loss program for people living with HIV. AIDS Behav. 2019.Google Scholar
- 66.Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, et al. A randomized placebo-controlled trial of low- versus moderate-dose vitamin D3 supplementation on bone mineral density in postmenopausal women with HIV. J Acquir Immune Defic Syndr. 2019;80(3):342–9.PubMedCrossRefPubMedCentralGoogle Scholar
- 67.Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.CrossRefGoogle Scholar
- 68.Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;17:CIR0000000000000678.Google Scholar